Orphazyme A/S sell Amped
Start price
21.06.21
/
0%
€6.30
Target price
21.06.22
-
Performance (%)
9.52%
End price
23.06.21
€6.90
Summary
This prediction ended on 23.06.21 with a price of €6.90. With a performance of 9.52%, the SELL prediction by Amped for Orphazyme A/S was trending in the wrong direction This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Orphazyme A/S | - | - | - | - |
iShares Core DAX® | 3.054% | -1.396% | 15.789% | 12.675% |
iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% | 39.325% |
iShares Nikkei 225® | 5.386% | -3.105% | 16.065% | 8.150% |
iShares S&P 500 | 2.955% | -3.011% | 25.903% | 37.650% |
According to Amped what are the pros and cons of Orphazyme A/S for the foreseeable future?
Pros
EBIT growth >5% per year expected
Capable Management
Known brand
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Good culture
Sustainability is important
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Few uniques
Dependend from some customers or products
Significant cyclical dependencies
Comments by Amped for this prediction
In the thread Orphazyme A/s diskutieren
Sell Orphazyme A/S
In the thread Trading Orphazyme A/s
Sell beendet
Stopped prediction by Amped for Orphazyme A/S
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.80
25.06.21
25.06.21
-
21.06.22
21.06.22
-88.60%
22.06.22
22.06.22
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€0.78
25.06.21
25.06.21
-
21.06.22
21.06.22
-
25.06.21
25.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.90
23.06.21
23.06.21
-
21.06.22
21.06.22
-1.45%
25.06.21
25.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.55
21.06.21
21.06.21
-
21.06.22
21.06.22
-3.82%
21.06.21
21.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products